pirfenidon stada 534 mg tabletki powlekane
stada arzneimittel ag - pirfenidonum - tabletki powlekane - 534 mg
pirfenidon stada 267 mg tabletki powlekane
stada arzneimittel ag - pirfenidonum - tabletki powlekane - 267 mg
pirfenidon stada 801 mg tabletki powlekane
stada arzneimittel ag - pirfenidonum - tabletki powlekane - 801 mg
clopidogrel acino
acino ag - klopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - Środki przeciwzakrzepowe - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.
jeanine 0,03 mg + 2 mg tabletki powlekane
bayer ag - ethinylestradiolum + dienogestum - tabletki powlekane - 0,03 mg + 2 mg
fluconazole b. braun 2 mg/ml 2 mg/ml roztwór do infuzji
b. braun melsungen ag - fluconazolum - roztwór do infuzji - 2 mg/ml
entecavir stada 0,5 mg tabletki powlekane
stada arzneimittel ag - entecavirum - tabletki powlekane - 0,5 mg
entecavir stada 1 mg tabletki powlekane
stada arzneimittel ag - entecavirum - tabletki powlekane - 1 mg
xalgin 500 mg tabletki
stada arzneimittel ag - metamizolum natricum monohydricum - tabletki - 500 mg
anagrelidum aop 0,5 mg kapsułki twarde
aop orphan pharmaceuticals ag - anagrelidum - kapsułki twarde - 0,5 mg